Inhibition of Interleukin-4 Signalling in the Treatment of Atopic Dermatitis and Allergic Asthma

Journal Title: Global Journal of Allergy - Year 2017, Vol 3, Issue 1

Abstract

Atopic dermatitis and allergic asthma result from amplified immune response to environmental antigens, and allergic reactions from released IgE, histamine, leukotrienes and cytokines. Environmental antigens immune cells, of innate and adaptive immunity, to stimulate interleukin-4 (IL-4) mediated activation of Th2 cells and subsequent isotype switching of B cells to produce IgE antibodies, responsible for the clinical manifestation of atopic diseases. The IL-4 receptor alpha chain (IL4Rα), which mediates IL-4 signaling, is common to IL-4 and IL-13 receptors, with IL-13 being an associated cytokine in the allergic response. US Food and Drug Administration recently approved dupilumab, which blocks IL4Rα for the treatment of moderate to severe atopic dermatitis. In controlled trials, dupilumab counteracted the allergic response and the clinical symptoms of dermatitis and asthma, and dupilumab was more effective than other available treatments. The primary safety concern of dupilumab is conjunctivitis and its long-term safety, which is unknown.

Authors and Affiliations

Philips Neena, Samuel Mathew

Keywords

Related Articles

Plastic Bronchitis: A Case Report

Plastic bronchitis is a rare disease characterized by the formation of bronchial casts that can cause partial or complete obstruction of the airway. In this case report, a patient aged four years, previously healthy, beg...

Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial

Purpose: Allergic rhinitis (AR) affects ~20% of the population worldwide. The objectives of this study were to evaluate the safety and efficacy of iodixanol nasal solution (Nasapaque) for AR treatment, using the Allergen...

Polyphenols and their Mechanism of Action in Allergic Immune Response

Mini review article deals with the most studied group of chemical compounds – polyphenols – predominantly flavonoids in relation to their allergic immune response. There is clarified and discussed their mechanism of acti...

Atopic Eczema - From Epidemiology to Therapeutic Approach

Atopic dermatitis is one of the epidemically expanding non-infectious diseases in the 21 century. It poses immense challenges to both patients and physicians. With a steady growth in its incidence and prevalence, the dis...

The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies

Background: Cysteinyl leukotriene levels are elevated in patients with atopic dermatitis, which can lead to eosinophilic infiltration of the gastrointestinal tract. Objective: We examined the role that montelukast (a le...

Download PDF file
  • EP ID EP342770
  • DOI 10.17352/2455-8141.000019
  • Views 65
  • Downloads 0

How To Cite

Philips Neena, Samuel Mathew (2017). Inhibition of Interleukin-4 Signalling in the Treatment of Atopic Dermatitis and Allergic Asthma. Global Journal of Allergy, 3(1), 19-21. https://europub.co.uk/articles/-A-342770